Moderna (MRNA)

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-27 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Moderna, Inc. (MRNA) CIK: 0001682852 --- Reporting Owner --- Name: Klinger Shannon Thyme CIK: 0001866132 Role: Officer (Chief Legal Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-27 | Code: M (Exercise of derivative) Shares: +774 Shares Owned After: 74,335 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [Transaction #2] Security: Common Stock Date: 2026-08-27 | Code: F (Payment of exercise/tax) Shares: -375 | Price: $149.66 Total Value: $56,122.50 Shares Owned After: 73,960 | Ownership: D (Direct) Footnotes: [F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. [Transaction #3] Security: Common Stock Date: 2026-08-28 | Code: M (Exercise of derivative) Shares: +329 Shares Owned After: 74,289 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [Transaction #4] Security: Common Stock Date: 2026-08-28 | Code: F (Payment of exercise/tax) Shares: -160 | Price: $142.77 Total Value: $22,843.20 Shares Owned After: 74,129 | Ownership: D (Direct) Footnotes: [F2] Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Units Date: 2026-08-27 | Code: M (Exercise of derivative) Shares: -774 | Price: $0.00 Shares Owned After: 4,642 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [F3] 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. [F3] 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. [Transaction #2] Security: Restricted Stock Units Date: 2026-08-28 | Code: M (Exercise of derivative) Shares: -329 | Price: $0.00 Shares Owned After: 658 | Ownership: D (Direct) Footnotes: [F1] Restricted stock units convert into common stock on a one-for-one basis. [F1] Restricted stock units convert into common stock on a one-for-one basis. [F4] 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. [F4] 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Footnotes (Complete Index) --- F1: Restricted stock units convert into common stock on a one-for-one basis. F2: Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. F3: 25% of the shares subject to this restricted stock unit award vested on February 27, 2025 with the remainder vesting in twelve (12) equal quarterly installments thereafter. F4: 25% of the shares subject to this restricted stock unit award vested on February 28, 2024 with the remainder vesting in twelve (12) equal quarterly installments thereafter. --- Signature --- /s/ /s/ James Dillon, as Attorney-in-Fact (2026-08-31)